Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seitaro Terakura

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Cytotherapy|January 13, 2026
Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphomaTakuya Kawaguchi, Kazuyuki Shimada, Katsuya Furukawa, et al.
Transplantation|May 15, 2007
A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403Seitaro Terakura, Makoto Murata, Edus H Warren, et al.
Blood|October 28, 2011
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsSeitaro Terakura, Tori N Yamamoto, Rebecca A Gardner, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Cellular kinetics and outcome of tisagenlecleucel for diffuse large B-cell lymphoma]Ryo Hanajiri, Katsuya Furukawa, Marie Nakashima, et al.
Anticancer Research|July 24, 2010
Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemiaSatoshi Nishiwaki, Koichi Miyamura, Chiaki Kato, et al.
Journal for Immunotherapy of Cancer|March 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesisYuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology|March 28, 2008
Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotypeKyoko Sugimoto, Makoto Murata, Makoto Onizuka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 6, 2018
[MonoMAC syndrome patient developing myelodysplastic syndrome following persistent EBV infection]Hideyuki Yamamoto, Hikaru Hattori, Erina Takagi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 7, 2020
Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cellsNaoyuki Tange, Fumihiko Hayakawa, Takahiko Yasuda, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Cytotherapy|January 13, 2026
Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphomaTakuya Kawaguchi, Kazuyuki Shimada, Katsuya Furukawa, et al.
Transplantation|May 15, 2007
A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403Seitaro Terakura, Makoto Murata, Edus H Warren, et al.
Blood|October 28, 2011
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsSeitaro Terakura, Tori N Yamamoto, Rebecca A Gardner, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Cellular kinetics and outcome of tisagenlecleucel for diffuse large B-cell lymphoma]Ryo Hanajiri, Katsuya Furukawa, Marie Nakashima, et al.
Anticancer Research|July 24, 2010
Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemiaSatoshi Nishiwaki, Koichi Miyamura, Chiaki Kato, et al.
Journal for Immunotherapy of Cancer|March 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesisYuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology|March 28, 2008
Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotypeKyoko Sugimoto, Makoto Murata, Makoto Onizuka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 6, 2018
[MonoMAC syndrome patient developing myelodysplastic syndrome following persistent EBV infection]Hideyuki Yamamoto, Hikaru Hattori, Erina Takagi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 7, 2020
Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cellsNaoyuki Tange, Fumihiko Hayakawa, Takahiko Yasuda, et al.
Pageof 12